Lentiviral infection of rhesus macaques causes long-term injury to cortical and hippocampal projections of prostaglandin-expressing cholinergic basal forebrain neurons

Journal of Neuropathology and Experimental Neurology

Volumn 71, Issue 1, 2012, Pages 15-27

  Depboylu, Candan ^a   Weihe, Eberhard ^a   Eiden, Lee E ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

AIDS; Antiretroviral treatment; Cholinergic; Dementia; Encephalitis; Prostaglandins

Indexed keywords

6 CHLORO 2',3' DIDEOXYGUANOSINE; CHOLINE ACETYLTRANSFERASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DIDEOXYNUCLEOTIDE; PROSTAGLANDIN; UNCLASSIFIED DRUG; VESICULAR ACETYLCHOLINE TRANSPORTER;

ARTICLE; CHOLINERGIC NERVE CELL; ENCEPHALITIS; ENTORHINAL CORTEX; FRONTAL CORTEX; HUMAN; LENTIVIRUS INFECTION; NONHUMAN; PARIETAL CORTEX; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN IMMUNODEFICIENCY VIRUS INFECTION; TELENCEPHALON;

ANIMALS; BRAIN INJURIES; CEREBRAL CORTEX; CHOLINERGIC NEURONS; HIPPOCAMPUS; LENTIVIRUS INFECTIONS; MACACA MULATTA; NEURAL PATHWAYS; PROSENCEPHALON; PROSTAGLANDINS; RETROVIRUSES, SIMIAN; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; TIME FACTORS;

EID: 84655169662     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e31823cfac5     Document Type: Article

References (55)

1. Sacktor N, McDermott MP, Marder K, et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 2002;8:136-42 (Pubitemid 34520894)
2. Tozzi V, Balestra P, Murri R, et al. Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART. Int J STD AIDS 2004;15:254-59 (Pubitemid 38570132)
3. Murray EA, Rausch DM, Lendvay J, et al. Cognitive and motor impairments associated with SIV infection in rhesus monkeys. Science 1992; 255:1246-49
4. Ellis R, Langford D, Masliah E. HIV and antiretroviral therapy in the brain: Neuronal injury and repair. Nat Rev Neurosci 2007;8:33-44 (Pubitemid 46011997)
5. da Cunha A, Rausch DM, Eiden LE. Early alterations in density of somatostatin mRNA-expressing neurons in frontal cortex of SIV-infected rhesus macaque. Proc Natl Acad Sci USA 1995;92:1371-75
6. Bissel SJ, Wang G, Ghosh M, et al. Macrophages relate presynaptic and postsynaptic damage in simian immunodeficiency virus encephalitis. Am J Pathol 2002;160:927-41 (Pubitemid 34224582)
7. Weed MR, Gold LH, Polis I, et al. Impaired performance on a rhesus monkey neuropsychological testing battery following simian immunodeficiency virus infection. AIDS Res Hum Retroviruses 2004;20:77-89 (Pubitemid 38147179)
8. Sailasuta N, Shriner K, Ross B. Evidence of reduced glutamate in the frontal lobe of HIV-seropositive patients. NMR Biomed 2009;22:326-31
9. Mesulam M-M, Mufson EJ, Levey AI, et al. Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol 1983;214:170-97 (Pubitemid 13162962)
10. Mesulam MM, Mufson EJ, Levey AI, et al. Atlas of cholinergic neurons in the forebrain and upper brainstem of the macaque based on monoclonal choline acetyltransferase immunohistochemistry and acetylcholinesterase histochemistry. Neuroscience 1984;12:669-86 (Pubitemid 14092485)
11. Bartus RT, Dean RL 3rd, Beer B, et al. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982;217:408-17 (Pubitemid 12048290)
12. Price DL, Martin LJ, Clatterbuck RE, et al. Neuronal degeneration in human diseases and animal models. J Neurobiol 1992;23:1277-93
13. Chen KS, Masliah E, Mallory M, et al. Synaptic loss in cognitively impaired aged rats is ameliorated by chronic human nerve growth factor infusion. Neuroscience 1995;68:19-27
14. Liberini P, Cuello AC. Primate models of cholinergic dysfunction. Funct Neurol 1995;10:45-54
15. Forster MJ, Dubey A, Dawson KM, et al. Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain. Proc Natl Acad Sci USA 1996;93:4765-69 (Pubitemid 26162825)
16. Davies P, Maloney MR. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976;2:1403 (Pubitemid 8004505)
17. Perry EK, Perry RH, Blessed G, et al. Necropsy evidence of central cholinergic deficits in senile dementia. Lancet 1977;1:189 (Pubitemid 8020501)
18. Coyle JT, Price DL, DeLong MR. Alzheimer's disease: A disorder of cortical cholinergic innervation. Science 1983;219:1184-90 (Pubitemid 13160659)
19. Beach TG, Honer WG, Hughes LH. Cholinergic fiber loss associated with diffuse plaques in the non-demented elderly: The preclinical stage of Alzheimer's disease? Acta Neuropathol 1997;93:146-53 (Pubitemid 27060906)
20. Bird TD, Stranahan S, Sumi SM, et al. Alzheimer's disease: Choline acetyltransferase activity in brain tissue from clinical and pathological subgroups. Ann Neurol 1983;14:284-93 (Pubitemid 13051231)
21. Henke H, Lang W. Cholinergic enzymes in neocortex, hippocampus and basal forebrain of nonneurological and senile dementia of Alzheimer-type patients. Brain Res 1983;267:281-91 (Pubitemid 13081888)
22. Sims NR, Bowen DM, Allen SJ, et al. Presynaptic cholinergic dysfunction in patients with dementia. J Neurochem 1983;40:503-9 (Pubitemid 13195690)
23. Ruberg M, Mayo W, Brice A, et al. Choline acetyltransferase activity and [3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions. Neuroscience 1990;35:327-33 (Pubitemid 20176745)
24. Strada O, Vyas S, Hirsch EC, et al. Decreased choline acetyltransferase mRNA expression in the nucleus basalis of Meynert in Alzheimer disease: An in situ hybridization study. Proc Natl Acad Sci USA 1992;89: 9549-53
25. Kuhl DE, Minoshima S, Fessler JA, et al. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Ann Neurol 1996;40:399-410 (Pubitemid 26304797)
26. Efange SMN, Garland EM, Staley JK, et al. Vesicular acetylcholine transporter density and Alzheimer's disease. Neurobiol Aging 1997;18: 407-13 (Pubitemid 27435083)
27. Fischer W, Wictorin K, Bjorklund A, et al. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 1987;329:65-68 (Pubitemid 17125895)
28. Mufson EJ, Lavine N, Jaffar S, et al. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Exp Neurol 1997;146:91-103 (Pubitemid 27319723)
29. Beal MF, MacGarvey U, Schwartz KJ. Galanin immunoreactivity is increased in the nucleus basalis of Meynert in Alzheimer's disease. Ann Neurol 1990;28:157-61 (Pubitemid 20244516)
30. Depboylu C, Reinhart TA, Takikawa O, et al. Brain virus burden and indoleamine-2,3-dioxygenase expression during lentiviral infection of rhesus monkey are concomitantly lowered by 6-chloro-2, 3-dideoxyguanosine. Eur J Neurosci 2004;19:2997-3005 (Pubitemid 38822590)
31. Depboylu C, Eiden LE, Schäfer MK, et al. Fractalkine expression in the rhesus monkey brain during lentivirus infection and its control by 6-chloro-2,3-dideoxyguanosine. J Neuropathol Exp Neurol 2006;65: 1170-80 (Pubitemid 44885941)
32. Depboylu C, Weihe E, Eiden LE. COX1 and COX2 expression in nonneuronal cellular compartments of the rhesus macaque brain during lentiviral infection. Neurobiol Dis 2011;42:108-15
33. Tsubokura S, Watanabe Y, Ehara H, et al. Localization of prostaglandin endoperoxide synthase in neurons and glia in monkey brain. Brain Res 1991;543:15-24
34. Breder CD, Smith WL, Raz A, et al. Distribution and characterization of cyclooxygenase immunoreactivity in the ovine brain. J Comp Neurol 1992;322:409-38
35. Breder CD, Dewitt D, Kraig RP. Characterization of inducible cyclooxygenase in rat brain. J Comp Neurol 1995;355:296-315
36. Yamagata K, Andreasson KI, Kaufmann WE, et al. Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids. Neuron 1993;11:371-86 (Pubitemid 23250354)
37. Wong PT, McGeer PL, McGeer EG. Decreased prostaglandin synthesis in postmortem cerebral cortex from patients with Alzheimer's disease. Neurochem Int 1992;21:197-202
38. Lukiw WJ, Bazan NG. Cyclooxygenase 2 RNA message abundance, stability, and hypervariability in sporadic Alzheimer neocortex. J Neurosci Res 1997;50:937-45 (Pubitemid 28034648)
39. Lukiw WJ, Bazan NG. Strong nuclear factor-JB DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer's disease superior temporal lobe neocortex. J Neurosci Res 1998;53:583-92 (Pubitemid 28380799)
40. Tocco G, Freire-Moar J, Schreiber SS, et al. Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: Implications for Alzheimer's disease. Exp Neurol 1997;144:339-49 (Pubitemid 27224561)
41. Choi S-H, Aid S, Bosetti F. The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: Implications for translational research. Trends Pharmacol Sci 2009;30:174-81
42. Choi S-H, Aid S, Choi U, et al. Cyclooxygenase-1 and -2 differentially modulate leukocyte recruitment into the inflamed brain. Pharmacogenomics 2010;10:448-57
43. Inoue M, Crofton JT, Share L. Interactions between brain acetylcholine and prostaglandins in control of vasopressin release. Am J Physiol 1991; 261:R420-26
44. Orman B, Reina S, Borda E, et al. Signal transduction underlying carbachol-induced PGE2 generation and cox-1 mRNA expression of rat brain. Neuropharmacology 2005;48:757-65 (Pubitemid 40462414)
45. Vesin MF, Urade Y, Hayaishi O, et al. Neuronal and glial prostaglandin D synthase isozymes in chick dorsal root ganglia: A light and electron microscopic immunocytochemical study. J Neurosci 1995;15:470-76
46. Liang X, Wu L, Hand T, et al. Prostaglandin D2 mediates neuronal protection via the DP1 receptor. J Neurochem 2005;92:477-86 (Pubitemid 40189451)
47. Masliah E, Heaton RK, Marcotte TD, et al. Dendritic injury is a pathological substrate for human immunodeficiency virusYrelated cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol 1997;42:963-72 (Pubitemid 28008427)
48. Masliah E, Ge N, Morey M, et al. Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab Invest 1992;66:285-91
49. Li Q, Eiden LE, Cavert W, et al. Increased expression of nitric oxide synthase and dendritic injury in simian immunodeficiency virus encephalitis. J Hum Virol 1999;2:139-45 (Pubitemid 30263448)
50. Wiley CA. Implications of the neuropathology of HIV encephalitis for the pathogenesis of Alzheimer disease. Alzheimer Dis Assoc Disord 1987;1:236-50
51. Xing HQ, Moritoyo T, Mori K, et al. Simian immunodeficiency virus encephalitis in the white matter and degeneration of the cerebral cortex occur independently in simian immunodeficiency virusYinfected monkey. J Neurovirol 2003;9:508-18 (Pubitemid 36986817)
52. Xing HQ, Mori K, Sugimoto C, et al. Impaired astrocytes and diffuse activation of microglia in the cerebral cortex in simian immunodeficiency virusYinfected macaques without simian immunodeficiency virus encephalitis. J Neuropathol Exp Neurol 2008;67:600-11 (Pubitemid 351787086)
53. Xing HQ, Hayakawa H, Gelpi E, et al. Reduced expression of excitatory amino acid transporter 2 and diffuse microglial activation in the cerebral cortex in AIDS cases with or without HIV encephalitis. J Neuropathol Exp Neurol 2009;68:199-209
54. Gray RA, Wilcox KM, Zink MC, et al. Impaired performance on the object retrieval-detour test of executive function in the SIV/macaque model of AIDS. AIDS Res Hum Retroviruses 2006;22:1031-35 (Pubitemid 46100689)
55. Griffin DE, Wesselingh SL, McArthur JC. Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Ann Neurol 1994;35:592-97